secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2026-03-26T23:59:59+00:00
Accession:  0001628280-26-021464
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sanuwave records Q4 revenue $13.4M (+29.7% YoY); FY rev $44.1M; guides FY26 $51-55M
--------------------------------------------------------------------------------

- Q4 2025 revenue record $13.4M (+29.7% YoY); FY 2025 revenue record $44.1M (+35% YoY).
- GAAP operating income $2.0M Q4 ($4.9M FY); net income $7.7M Q4 vs loss $13.3M Q4 2024.
- Adjusted EBITDA Q4 $4.8M vs $3.7M YoY; FY $13.6M vs $7.2M YoY.
- Guides Q1 2026 rev $9.6-10.3M (+3-10%); FY 2026 rev $51-55M (+16-25% vs FY25).
- Sold 255 UltraMist systems in Q4 (up from 135); consumables rev +10.6% to $6.5M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000162828026021464/0001628280-26-021464-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000162828026021464/snwv-20260326.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-021464

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer